Intrust Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$717K Sell
11,432
-1,940
-15% -$155K 0.06% 217
2025
Q4
$1.28M Sell
13,372
-484
-3% -$47.5K 0.11% 137
2025
Q3
$1.35M Buy
13,856
+5
+0% +$518 0.11% 130
2025
Q2
$1.49M Buy
13,851
+929
+7% +$94K 0.13% 125
2025
Q1
$1.3M Buy
12,922
+950
+8% +$95.7K 0.13% 125
2024
Q4
$1.07M Buy
11,972
+795
+7% +$70K 0.11% 143
2024
Q3
$937K Buy
11,177
+301
+3% +$23.7K 0.09% 159
2024
Q2
$838K Buy
10,876
+147
+1% +$10.8K 0.09% 165
2024
Q1
$735K Sell
10,729
-496
-4% -$31.9K 0.08% 196
2023
Q4
$649K Buy
11,225
+730
+7% +$39K 0.08% 206
2023
Q3
$554K Buy
10,495
+581
+6% +$30.5K 0.07% 219
2023
Q2
$536K Sell
9,914
-45
-0.5% -$2.35K 0.07% 232
2023
Q1
$498K Buy
9,959
+758
+8% +$35.7K 0.06% 238
2022
Q4
$426K Buy
9,201
+684
+8% +$29.6K 0.06% 246
2022
Q3
$330K Buy
8,517
+2,382
+39% +$95.6K 0.05% 271
2022
Q2
$229K Sell
6,135
-120
-2% -$4.88K 0.03% 342
2022
Q1
$277K Buy
6,255
+664
+12% +$28.8K 0.04% 332
2021
Q4
$238K Buy
5,591
+610
+12% +$25.6K 0.03% 369
2021
Q3
$216K Sell
4,981
-116
-2% -$5.13K 0.03% 361
2021
Q2
$218K Sell
5,097
-1,231
-19% -$51.8K 0.03% 352
2021
Q1
$244K Sell
6,328
-826
-12% -$31.3K 0.04% 336
2020
Q4
$257K Sell
7,154
-142
-2% -$5.12K 0.04% 313
2020
Q3
$279K Buy
7,296
+455
+7% +$17.5K 0.05% 269
2020
Q2
$240K Sell
6,841
-69
-1% -$2.48K 0.05% 288
2020
Q1
$225K Buy
+6,910
New +$270K 0.06% 276

Other funds holding BSX

Intrust Bank's BSX Position: Q1 2026 in Review

Intrust Bank reduced its Boston Scientific (BSX) stake by 15% in Q1 2026, selling an estimated $155K and leaving 11,432 shares worth $717K. The position accounts for 0.06% of the portfolio, ranked #217.

Intrust Bank first reported a position in BSX in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.49M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Intrust Bank held 11,432 shares of Boston Scientific worth $717K as of Q1 2026.
  • Intrust Bank sold 1,940 Boston Scientific shares in Q1 2026, an estimated $155K.
  • Boston Scientific made up 0.06% of Intrust Bank's portfolio in Q1 2026, its #217 holding.
  • Intrust Bank first reported a position in Boston Scientific in Q1 2020 and has held it in 25 quarters since.
  • Intrust Bank's Boston Scientific position peaked at $1.49M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.